Chongqing Taiji Industry (Group) Co (SHSE:600129) Research & Development: ¥221 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600129 Chongqing Taiji Industry (Group) Co Ltd SHSE:600129
73 GF Score
Price ¥14.49
GF Value ¥21.07
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Chongqing Taiji Industry (Group) Co Research & Development?

Chongqing Taiji Industry (Group) Co SHSE:600129 -1.16% 73 Research & Development is ¥221 Mil as of Jun. 2026. GuruFocus rates SHSE:600129 with a GF Score™ of 73/100 and a GF Value™ of ¥21.07 (Possible Value Trap). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Chongqing Taiji Industry (Group) Co's Research & Development for the three months ended in Jun. 2026 was ¥50 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was ¥221 Mil.

Chongqing Taiji Industry (Group) Co  (SHSE:600129) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Chongqing Taiji Industry (Group) Co Research & Development Related Terms

Chongqing Taiji Industry (Group) Co Research & Development Historical Data

* Premium members only.

The historical data trend for Chongqing Taiji Industry (Group) Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chongqing Taiji Industry (Group) Co Research & Development Chart

Chongqing Taiji Industry (Group) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 102.55 109.42 233.62 279.57 257.54

Chongqing Taiji Industry (Group) Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.98 58.06 62.05 51.10 49.78
SHSE:600129
73GF Score
Chongqing Taiji Industry (Group) Co Ltd SHSE:600129
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chongqing Taiji Industry (Group) Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥221 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥221 Mil mean?
Chongqing Taiji Industry (Group) Co (SHSE:600129) has a Research & Development of ¥221 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Chongqing Taiji Industry (Group) Co and its competitors.
Is Chongqing Taiji Industry (Group) Co's Research & Development too high?
Chongqing Taiji Industry (Group) Co's current Research & Development is ¥221 Mil. Overall, Chongqing Taiji Industry (Group) Co has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Chongqing Taiji Industry (Group) Co's Research & Development compare to ZTS?
Chongqing Taiji Industry (Group) Co's Research & Development of ¥221 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Chongqing Taiji Industry (Group) Co and its competitors. Chongqing Taiji Industry (Group) Co's current Research & Development is ¥221 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Taiji Industry (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Taiji Industry (Group) Co (SHSE:600129) is currently considered Possible Value Trap. The stock's GF Value™ is ¥21.07, compared to a current price of ¥14.49 — trading 31.2% below its estimated fair value. The current Research & Development is ¥221 Mil. Chongqing Taiji Industry (Group) Co's overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Chongqing Taiji Industry (Group) Co (SHSE:600129), the current Research & Development is ¥221 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chongqing Taiji Industry (Group) Co (SHSE:600129) Overvalued in 2026?

Based on GuruFocus' analysis, Chongqing Taiji Industry (Group) Co stock appears to be undervalued. The current stock price of ¥14.49 is trading 31.2% below its estimated GF Value™ of ¥21.07. GuruFocus considers Chongqing Taiji Industry (Group) Co to be Possible Value Trap.

Key valuation signals for SHSE:600129:

  • Research & Development: ¥221 Mil
  • GF Value™: ¥21.07 vs. price of ¥14.49 (31.2% below fair value)
  • GF Score™: 73/100 with 8 warning signs

No single metric tells the full story. See the SHSE:600129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chongqing Taiji Industry (Group) Co Business Description

Address No. 18, Hengshan East Road, Yubei District, Chongqing, CHN, 401123
Chongqing Taiji Industry (Group) Co Ltd is a China-based company engaged in the production and sales of Chinese and Western medicines. It is also engaged in the cultivation of medicinal herbs. Its products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series, and injections. The company mainly conducts its business in domestic and overseas markets.
73GF Score

Get the complete analysis for SHSE:600129

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥14.49
Price
¥21.07
GF Value